AKT1 and urinary bladder carcinoma: As shown in Figure 4B, the phosphorylated levels of PI3K and AKT were markedly decreased in T24 and EJ cells after exposure to the increasing concentration of PPM-18, implying that PPM-18 could also inhibit PI3K and AKT pathways in bladder cancer cells.